Close

Ratings by H.C. Wainwright (Robert Burns)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/1/2024 Apollomics Inc. APLM Maintain Buy
(N/A)
 
 
  Details
3/28/2024 Nuvation Bio Inc NUVB Maintain Buy
(N/A)
 
 
  Details
3/21/2024 Calidi Biotherapeutics Inc CLDI Maintain Buy
(N/A)
 
 
  Details
3/21/2024 ORIC Pharamceuticals ORIC Maintain Buy
(N/A)
 
 
  Details
3/20/2024 Tango Therapeutics Inc. TNGX Maintain Buy
(N/A)
 
 
  Details
3/19/2024 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
3/12/2024 IGM Biosciences IGMS Maintain Neutral
(N/A)
 
 
  Details
3/7/2024 Nuvation Bio Inc NUVB Maintain Buy
(N/A)
 
 
  Details
3/6/2024 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details
3/6/2024 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
2/27/2024 Cogent COGT Maintain Buy
(N/A)
 
 
  Details
2/26/2024 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
2/20/2024 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
2/20/2024 Nurix NRIX Maintain Buy
(N/A)
 
 
  Details
2/20/2024 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details
2/20/2024 Prelude Therapeutics PRLD Downgrade Neutral
(Buy)
4.63
(4.91)
6.05% Details
2/14/2024 Repare Therapeutics RPTX Maintain Buy
(N/A)
 
 
  Details
2/7/2024 eFFECTOR Therapeutics, Inc. EFTR Maintain Buy
(N/A)
 
 
  Details
1/17/2024 Elicio Therapeutics ELTX Maintain Buy
(N/A)
 
 
  Details
1/8/2024 Portage Biotech inc. PRTG Downgrade Neutral
(Buy)
1.09
(0.28)
-74.31% Details
1/5/2024 Viracta Therapeutics VIRX Maintain Buy
(N/A)
 
 
  Details
12/19/2023 Kronos Bio Inc. KRON Maintain Buy
(N/A)
 
 
  Details
12/15/2023 Cogent COGT Maintain Buy
(N/A)
 
 
  Details
12/15/2023 Aadi Bioscience Inc AADI Downgrade Neutral
(Buy)
5.37
(1.79)
-66.67% Details
12/13/2023 ORIC Pharamceuticals ORIC Maintain Buy
(N/A)
 
 
  Details
12/11/2023 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
12/8/2023 IGM Biosciences IGMS Maintain Buy
(N/A)
 
 
  Details
12/7/2023 IGM Biosciences IGMS Downgrade Neutral
(Buy)
6.48
(9.20)
41.98% Details
11/30/2023 Portage Biotech inc. PRTG Maintain Buy
(N/A)
 
 
  Details
11/28/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
11/22/2023 Calidi Biotherapeutics Inc CLDI New Coverage Buy
(N/A)
1.70
(0.21)
-87.65% Details
11/20/2023 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
11/20/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
11/13/2023 Omega Therapeutics OMGA Maintain Buy
(N/A)
 
 
  Details
11/13/2023 Aadi Bioscience Inc AADI Maintain Buy
(N/A)
 
 
  Details
11/9/2023 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
11/9/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
11/9/2023 Atara Biotherapeutics ATRA Downgrade Neutral
(Buy)
1.21
(0.68)
-43.8% Details
11/7/2023 Prelude Therapeutics PRLD Maintain Buy
(N/A)
 
 
  Details
10/26/2023 ORIC Pharamceuticals ORIC Maintain Buy
(N/A)
 
 
  Details
10/26/2023 Elicio Therapeutics ELTX New Coverage Buy
(N/A)
6.50
(9.63)
48.15% Details
10/19/2023 Prelude Therapeutics PRLD Maintain Buy
(N/A)
 
 
  Details
10/17/2023 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
10/16/2023 PMV Pharmaceuticals Inc. PMVP Maintain Buy
(N/A)
 
 
  Details
10/3/2023 Apollomics Inc. APLM Maintain Buy
(N/A)
 
 
  Details
9/26/2023 Exelixis EXEL New Coverage Buy
(N/A)
21.83
(22.82)
4.54% Details
9/19/2023 Kinnate Biopharma KNTE Downgrade Neutral
(Buy)
1.70
(2.65)
55.88% Details
9/8/2023 Nurix NRIX Maintain Buy
(N/A)
 
 
  Details
8/24/2023 eFFECTOR Therapeutics, Inc. EFTR New Coverage Buy
(N/A)
0.71
(1.99)
180.28% Details
8/21/2023 Kronos Bio Inc. KRON Maintain Buy
(N/A)
 
 
  Details
8/17/2023 Repare Therapeutics RPTX Maintain Buy
(N/A)
 
 
  Details
8/17/2023 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
8/11/2023 PMV Pharmaceuticals Inc. PMVP Maintain Buy
(N/A)
 
 
  Details
8/11/2023 Tango Therapeutics Inc. TNGX Maintain Buy
(N/A)
 
 
  Details
8/8/2023 IGM Biosciences IGMS Maintain Buy
(N/A)
 
 
  Details
8/7/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
8/2/2023 Portage Biotech inc. PRTG Maintain Buy
(N/A)
 
 
  Details
7/26/2023 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
7/24/2023 Nurix NRIX Maintain Buy
(N/A)
 
 
  Details
7/5/2023 Viracta Therapeutics VIRX Maintain Buy
(N/A)
 
 
  Details
6/21/2023 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
6/14/2023 Atara Biotherapeutics ATRA Maintain Buy
(N/A)
 
 
  Details
6/12/2023 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
6/9/2023 Repare Therapeutics RPTX Maintain Buy
(N/A)
 
 
  Details
6/8/2023 Cogent COGT Maintain Buy
(N/A)
 
 
  Details
6/1/2023 Apollomics Inc. APLM New Coverage Buy
(N/A)
4.05
(0.54)
-86.67% Details
5/18/2023 Kinnate Biopharma KNTE Maintain Buy
(N/A)
 
 
  Details
5/10/2023 Viracta Therapeutics VIRX Maintain Buy
(N/A)
 
 
  Details
5/1/2023 Kineta Inc. KA New Coverage Buy
(N/A)
3.97
(0.48)
-87.91% Details
4/20/2023 Kinnate Biopharma KNTE Maintain Buy
(N/A)
 
 
  Details
4/4/2023 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details
4/3/2023 IGM Biosciences IGMS Maintain Buy
(N/A)
 
 
  Details
3/29/2023 Aadi Bioscience Inc AADI Maintain Buy
(N/A)
 
 
  Details
3/28/2023 Tango Therapeutics Inc. TNGX Maintain Buy
(N/A)
 
 
  Details
3/27/2023 Cogent COGT New Coverage Buy
(N/A)
10.11
(6.46)
-36.1% Details
3/20/2023 PMV Pharmaceuticals Inc. PMVP Maintain Buy
(N/A)
 
 
  Details
3/17/2023 Prelude Therapeutics PRLD Maintain Buy
(N/A)
 
 
  Details
3/14/2023 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
3/7/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
3/7/2023 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
2/9/2023 Atara Biotherapeutics ATRA Maintain Buy
(N/A)
 
 
  Details
1/4/2023 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
12/8/2022 Omega Therapeutics OMGA New Coverage Buy
(N/A)
6.30
(2.41)
-61.75% Details
12/1/2022 Portage Biotech inc. PRTG Maintain Buy
(N/A)
 
 
  Details
11/29/2022 Ikena Oconology IKNA Maintain Buy
(N/A)
 
 
  Details
11/18/2022 Kronos Bio Inc. KRON Maintain Buy
(N/A)
 
 
  Details
11/17/2022 PMV Pharmaceuticals Inc. PMVP Maintain Buy
(N/A)
 
 
  Details
11/17/2022 Prelude Therapeutics PRLD Maintain Buy
(N/A)
 
 
  Details
11/17/2022 Repare Therapeutics RPTX Maintain Buy
(N/A)
 
 
  Details
11/16/2022 Neoleukin Therapeutics NLTX Downgrade Neutral
(Buy)
0.42
(3.49)
730.95% Details
11/7/2022 IGM Biosciences IGMS Maintain Buy
(N/A)
 
 
  Details
11/7/2022 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
10/31/2022 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details
10/20/2022 Tango Therapeutics Inc. TNGX New Coverage Buy
(N/A)
6.98
(7.35)
5.3% Details
10/7/2022 Nurix NRIX Maintain Buy
(N/A)
 
 
  Details
9/20/2022 Portage Biotech inc. PRTG Maintain Buy
(N/A)
 
 
  Details
9/19/2022 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
9/13/2022 GT Biopharma Inc. GTBP Maintain Buy
(N/A)
 
 
  Details
9/12/2022 Neoleukin Therapeutics NLTX Maintain Buy
(N/A)
 
 
  Details
9/12/2022 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
9/12/2022 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
9/2/2022 Forma Therapeutics FMTX Downgrade Neutral
(Buy)
20.24
(20.01)
-1.14% Details
8/18/2022 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
8/9/2022 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
8/9/2022 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
7/28/2022 Kinnate Biopharma KNTE New Coverage Buy
(N/A)
12.04
(2.65)
-77.99% Details
7/11/2022 Nurix NRIX Maintain Buy
(N/A)
 
 
  Details
7/11/2022 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
7/11/2022 CytomX Therapeutics CTMX Downgrade Neutral
(Buy)
1.30
(1.86)
43.08% Details
6/6/2022 Repare Therapeutics RPTX Maintain Buy
(N/A)
 
 
  Details
6/6/2022 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
5/10/2022 Relay Therapeutics RLAY Maintain Buy
(N/A)
 
 
  Details
5/4/2022 Nuvation Bio Inc NUVB New Coverage Buy
(N/A)
4.78
(2.81)
-41.21% Details
4/14/2022 Nurix NRIX Maintain Buy
(N/A)
 
 
  Details
3/31/2022 IGM Biosciences IGMS Maintain Buy
(N/A)
 
 
  Details
3/7/2022 Portage Biotech inc. PRTG New Coverage Buy
(N/A)
7.87
(0.28)
-96.44% Details
12/29/2021 Nurix NRIX New Coverage Buy
(N/A)
30.16
(14.65)
-51.43% Details
12/23/2021 Ikena Oconology IKNA New Coverage Buy
(N/A)
15.01
(1.27)
-91.54% Details
12/22/2021 CytomX Therapeutics CTMX Maintain Buy
(N/A)
 
 
  Details
12/20/2021 Autolus Therapeutics plc AUTL Maintain Buy
(N/A)
 
 
  Details
8/30/2021 Aadi Bioscience Inc AADI Maintain Buy
(N/A)
 
 
  Details
7/29/2021 PMV Pharmaceuticals Inc. PMVP New Coverage Buy
(N/A)
35.66
(1.60)
-95.51% Details
7/21/2021 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
7/8/2021 Aerpio Pharmaceuticals ARPO Upgrade Buy
(Neutral)
1.71
(2.20)
28.65% Details
6/28/2021 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details
6/24/2021 Kronos Bio Inc. KRON New Coverage Buy
(N/A)
23.85
(1.09)
-95.43% Details
6/21/2021 Molecular Partners MOLN New Coverage Buy
(N/A)
19.26
(3.91)
-79.7% Details
5/24/2021 GT Biopharma Inc. GTBP New Coverage Buy
(N/A)
14.36
(3.70)
-74.23% Details
5/5/2021 Atara Biotherapeutics ATRA Maintain Neutral
(N/A)
 
 
  Details
5/3/2021 Viracta Therapeutics VIRX New Coverage Buy
(N/A)
10.80
(0.71)
-93.43% Details
4/26/2021 ADC Technologies ADCT Maintain Buy
(N/A)
 
 
  Details
4/26/2021 Prelude Therapeutics PRLD New Coverage Buy
(N/A)
34.59
(4.91)
-85.81% Details
3/2/2021 Atara Biotherapeutics ATRA Maintain Buy
(N/A)
 
 
  Details
2/25/2021 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
12/28/2020 Autolus Therapeutics AUTL New Coverage Buy
(N/A)
8.90
(4.86)
-45.39% Details
9/14/2020 Immunomedics IMMU Downgrade Neutral
(Buy)
42.25
(87.86)
107.95% Details
7/1/2020 IGM Biosciences IGMS New Coverage Buy
(N/A)
73.00
(9.20)
-87.4% Details
6/15/2020 Atara Biotherapeutics ATRA New Coverage Buy
(N/A)
9.38
(0.68)
-92.75% Details
5/14/2020 CytomX Therapeutics CTMX Maintain Buy
(N/A)
 
 
  Details
4/23/2020 Immunomedics IMMU Maintain Buy
(N/A)
 
 
  Details
4/13/2020 Neoleukin Therapeutics NLTX New Coverage Buy
(N/A)
11.35
(3.49)
-69.25% Details
1/28/2020 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details